Niiki Pharma

Philadelphia, United States Founded: 2007 • Age: 19 yrs Acquired By Intezyne
Oncology company specializing in cancer treatments

About Niiki Pharma

Niiki Pharma is a company based in Philadelphia (United States) founded in 2007 was acquired by Intezyne in June 2013.. Niiki Pharma has raised $1.94 million across 4 funding rounds from investors including Intezyne and Ben Franklin Technology Partners. Niiki Pharma operates in a competitive market with competitors including Moderna, Jazz Pharmaceuticals, BeiGene, Advanced Accelerator Applications and Incyte, among others.

  • Headquarter Philadelphia, United States
  • Sectors
    Healthcare
  • Phone
    *********
  • Website
    *********
  • Social
    *********
Operational Areas
Healthcare → Healthcare Products & Supplies
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Total Equity Funding
    $1.94 M (USD)

    in 4 rounds

  • Latest Funding Round
    $1.69 M (USD), Series A

    Aug 10, 2011

  • Investors
    Intezyne

    & 1 more

  • Employee Count
    Employee Count
  • Acquired by
    Intezyne

    (Jun 19, 2013)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of Niiki Pharma

Niiki Pharma has successfully raised a total of $1.94M across 4 strategic funding rounds. The most recent funding activity was a Series A round of $1.69 million completed in August 2011. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 4
  • Last Round Series A — $1.7M
  • First Round

    (06 Jan 2009)

  • Investors Count 1
Date Amount Transaction Name Valuation Lead Investors Investors
Aug, 2011 Amount Series A - Niiki Pharma Valuation

investors

Jul, 2010 Amount Debt – Conventional - Niiki Pharma Valuation

investors

Mar, 2009 Amount Seed - Niiki Pharma Valuation Ben Franklin Technology Partners
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Niiki Pharma

Niiki Pharma has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include Intezyne and Ben Franklin Technology Partners. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Investor Description Founded Year Domain Location
Technology ecosystem growth is supported in Southeastern Pennsylvania.
Founded Year Domain Location
Nanotechnology platform for targeted tumor drug delivery is developed.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Niiki Pharma

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Niiki Pharma

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Niiki Pharma Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Niiki Pharma

Niiki Pharma operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Moderna, Jazz Pharmaceuticals, BeiGene, Advanced Accelerator Applications and Incyte, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
mRNA-based therapeutics for diseases including cancer and infections are developed.
domain founded_year HQ Location
Novel biopharmaceutical medicines are developed for unmet medical needs.
domain founded_year HQ Location
Targeted and immune-oncology drugs for cancer treatment are developed.
domain founded_year HQ Location
Radiopharmaceuticals for oncology diagnostics and therapies are developed and marketed.
domain founded_year HQ Location
Small molecules are developed for cancer and skin disease treatments.
domain founded_year HQ Location
Cancer therapies are developed using selective pathway inhibitors.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Niiki Pharma

Frequently Asked Questions about Niiki Pharma

When was Niiki Pharma founded?

Niiki Pharma was founded in 2007 and raised its 1st funding round 2 years after it was founded.

Where is Niiki Pharma located?

Niiki Pharma is headquartered in Philadelphia, United States. It is registered at Philadelphia, Pennsylvania, United States.

Is Niiki Pharma a funded company?

Niiki Pharma is a funded company, having raised a total of $1.94M across 4 funding rounds to date. The company's 1st funding round was a Seed of $250K, raised on Jan 06, 2009.

What does Niiki Pharma do?

Niiki Pharma is a development focused oncology company specializing in first-in-class cancer treatments directed at novel cellular targets and related companion diagnostics. The company had a pipeline of various molecules in this segment. It was acquired by Intezyne in 2013.

Who are the top competitors of Niiki Pharma?

Niiki Pharma's top competitors include Moderna, Jazz Pharmaceuticals and Advanced Accelerator Applications.

Who are Niiki Pharma's investors?

Niiki Pharma has 2 investors. Key investors include Intezyne, and Ben Franklin Technology Partners.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available